London, 27 February 2018: City of London law firm Druces has advised the Montreux Healthcare Fund PLC on its acquisition of Active Assistance, the leading provider of care and support for individuals with complex neurological conditions.
Active Assistance provides specialist care to individuals with acquired brain injury and spinal cord injury in domiciliary and residential settings. It also owns the UK’s largest Case Management Group, serving clients with an acquired brain injury and other neurological conditions, throughout the care pathway.
The acquisition constitutes the second major transaction to complete within the last month for the fund, following the sale of The Regard Group earlier in the month. Active Assistance will offer a new platform from which to consolidate the highly fragmented specialist care sector through its next investment cycle.
The Druces team was led by Christopher Axford, Partner in the firm’s Corporate & Commercial team, and included Antony Cotton (Senior Associate; Corporate), Caroline Cropley (Senior Associate; Corporate), Rebecca Pinder (Solicitor; Corporate), Claire Rigby (Associate; Corporate), Toby Stroh (Partner; Corporate), Sophie Vann (Associate; Banking & Finance), Nicholas Brent (Partner; Property), Sarah Dahabiyeh (Associate; Property), Rebecca Facey (Associate; Property), Emma Foster (Senior Associate; Property), Lauren Sandland (Associate; Property), Paul White (Partner; Tax).
Oliver Harris, Montreux Healthcare Fund, comments:
“Following our success in the competitive bidding process for Active Assistance against several other potential bidders, Druces worked well with our bid team to get this deal across the line in an extremely tight timeframe over the Christmas period”.
Christopher Axford, Druces, comments:
“We are pleased to be supporting Montreux in their ambitious growth strategy for the Healthcare Fund. The deal will continue to allow Active Assistance to lead the way in specialist care, while also providing value to investors.
“The continued growth in healthcare, combined with the UK’s ageing population, and strong domestic earnings have helped maintain the attractiveness of healthcare businesses to investors. We expect to see more deals of this kind over the next 12 months.”
For further information or media enquiries contact:
Head of Business Development
D +44 (0)20 7216 5539